Quick Answer
Hepion Pharmaceuticals, Inc. reported Research And Development Expense of $445.5 thousand for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed a decrease of -96.2% in Research And Development Expense from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2014 to 2025), Hepion Pharmaceuticals, Inc.'s Research And Development Expense has grown by 41.8%.
- Historical annual values: Fiscal year 2025: $445.5 thousand | Fiscal year 2024: $11.85 million | Fiscal year 2023: $35.64 million | Fiscal year 2022: $33.27 million | Fiscal year 2021: $20.40 million | Fiscal year 2020: $12.00 million | Fiscal year 2019: $3.18 million | Fiscal year 2018: $7.59 million | Fiscal year 2017: $13.37 million | Fiscal year 2017: $13.65 million | Fiscal year 2016: $15.02 million | Fiscal year 2015: $8.40 million | Fiscal year 2014: $314.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: